MAPK3 and pancreatic neoplasm: Kmp in dosage-dependent manner prevents the pancreatic cancerous cells growth in PANC-1, MIA PaCa-2 and SNU213-pancreatic cancer cell line by causing apoptosis [173] and efficiently preventing ERK-1/2, EGFR-related AKT and Src signalling pathways and migration of cells [174].